Author: Emily

Custom Cell Culture for Diagnostic Companies: Consistency You Can Build an Assay Around

Custom Cell Culture for Diagnostic Companies: Consistency You Can Build an Assay Around Custom cell culture for diagnostic companies is not simply cell expansion. It is a tailored production program built around the documentation requirements, lot specifications, and performance consistency that diagnostic manufacturing demands. When a diagnostic assay depends on a cell line performing identically … Continue reading Custom Cell Culture for Diagnostic Companies: Consistency You Can Build an Assay Around

Large-Scale Cell Culture Expansion: Key Challenges and How to Overcome Them

Large-Scale Cell Culture Expansion: Key Challenges and How to Overcome Them Large-scale cell culture expansion is harder than it looks on paper. The process that works reliably at bench scale, clean viability numbers, consistent growth kinetics, predictable yields, often behaves differently once you move into spinner flasks, roller bottles, or stacked multi-layer systems. The biology … Continue reading Large-Scale Cell Culture Expansion: Key Challenges and How to Overcome Them

Scaling Antibody Production in CHO Cells: A Process Development Guide

Scaling Antibody Production in CHO Cells: A Process Development Guide Antibody production in CHO cells is the gold standard in biologic manufacturing. Chinese hamster ovary cells combine the post-translational modification machinery, glycosylation fidelity, and suspension scalability that monoclonal antibody programs require. But high-yield, consistent production does not happen by accident. It requires deliberate process development … Continue reading Scaling Antibody Production in CHO Cells: A Process Development Guide

Transient vs Stable Cell Line: A Decision Framework for Protein Production Programs

Transient vs Stable Cell Line: A Decision Framework for Protein Production Programs The transient vs stable cell line decision comes early in nearly every protein production program. It shapes your timeline, budget, and regulatory pathway, so getting it right from the start matters. This guide breaks down the transient vs stable cell line question into … Continue reading Transient vs Stable Cell Line: A Decision Framework for Protein Production Programs

Master Cell Banking for Diagnostic Reagent Manufacturers: Protecting Your Most Valuable Asset

Master Cell Banking for Diagnostic Reagent Manufacturers: Protecting Your Most Valuable Asset Master cell banking for diagnostic reagent manufacturers is one of the most critical investments you can make in your product program. When your assay depends on a specific cell line, a lost or degraded bank can halt production, delay supply, and threaten your … Continue reading Master Cell Banking for Diagnostic Reagent Manufacturers: Protecting Your Most Valuable Asset